Leadership Team


SJ Sung Joo Lee
Founder & CEO

Throughout his career at Sanofi and LG Chem, SJ has worked to improve the therapeutic landscape for various diseases, including hepatitis B, hepatocellular carcinoma (HCC), diabetes, and Alzheimer’s disease.


Peter Park
Chief Scientific Officer

Peter is a drug discovery executive working on targeted therapeutics for oncology, overseeing discovery and development of novel therapeutics based on cell-penetrating antibody platform. He is the co-inventor of Isatuximab during tenure at Immunogen.


K Ki Hwan Chang
Research Director

K is an experienced biomedical scientist with a demonstrated history of discovering antibody drugs, a couple of them in clinical trials. He has held antibodies drug discovery leadership positions at CJ, GC Pharma, and Mogam.


Yong-Sung KIM
Scientific co-founder

Yong-Sung is Professor at Ajou University and a pioneer in antibody engineering for therapeutic applications. He has published more than 95 peer-reviewed articles and holds multiple domestic and international patents.


 Board of Directors

SJ Sung Joo Lee, PhD
Chairman, Orum

Peter U. Park, PhD
Board of Director, Orum

Junghee Lim
Board of Director, Intervest